Exploring the challenges for pricing and reimbursement of high-cost combination therapies

Gain market access insight from payer and pricing experts from across the EU into:

  • the reimbursement mechanisms for combination products
  • the access challenges these mechanisms present for new innovative combinations
  • the scope for potential solutions
  • the policy direction in France, Germany, and the UK

FREE EBOOK

Free download

Latest insights

The evolution of the PRMA Healthcheck®

ICER 2020 value assessment framework: 7 updates that market ...

How collaboration and connectivity can accelerate payer ...